Mesirow Institutional Investment Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,653
Closed -$383K 132
2024
Q2
$383K Sell
4,653
-136,470
-97% -$10M 0.03% 118
2024
Q1
$9.36M Sell
141,123
-14,559
-9% -$898K 0.83% 69
2023
Q4
$8.84M Buy
+155,682
New +$8.16M 0.83% 69

Other funds holding LMAT

Mesirow Institutional Investment Management's LMAT Position: Q3 2024 in Review

Mesirow Institutional Investment Management sold out of LeMaitre Vascular (LMAT) in Q3 2024, closing a stake of 4,653 shares — an estimated $383K sold.

Mesirow Institutional Investment Management first reported a position in LMAT in Q4 2023 and held it in 3 quarters. The position peaked at $9.36M in Q1 2024. 291 funds tracked by Wall St. Rank hold LMAT as of Q3 2024.

  • Mesirow Institutional Investment Management reported no remaining LeMaitre Vascular position as of Q3 2024 after selling out during the quarter.
  • Mesirow Institutional Investment Management sold 4,653 LeMaitre Vascular shares in Q3 2024, an estimated $383K.
  • Mesirow Institutional Investment Management first reported a position in LeMaitre Vascular in Q4 2023 and held it in 3 quarters.
  • Mesirow Institutional Investment Management's LeMaitre Vascular position peaked at $9.36M in Q1 2024.
  • 291 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2024.

Based on Mesirow Institutional Investment Management's 13F filing for Q3 2024, filed 13 Nov 2024.